Chida K, Ohkawa S, Imai T, Suzuki Y, Ishikawa K, Watanabe C, Kuramoto K, Suzuki Y, Kaku T, Ueda K
Division of Cardiology, Tokyo Metropolitan Geriatric Hospital.
Nihon Ronen Igakkai Zasshi. 1993 Oct;30(10):869-78. doi: 10.3143/geriatrics.30.869.
Ninety-five patients aged 60 years or over with a permanent pacemaker implanted for sick sinus syndrome were divided into two groups: 32 patients with physiological pacing (group P) and 63 patients with ventricular pacing (group V). The mean follow-up period was 45.0 +/- 36.6 months in group P and 50.3 +/- 37.8 months in group V. Paroxysmal atrial fibrillation (Af) occurred in 28% of group P and 71% of group V (p < 0.05). The incidence of stable Af was also lower in group P than in group V (9% vs. 30%, p < 0.05). None of group P with only bradyarrhythmia had stable Af. However, 6 of 21 patients (29%) in group V with bradyarrhythmia showed stable Af. There was no significant difference in stable Af between group P with bradycardia-tachycardia syndrome (BTS) and group V with BTS (19% vs. 31%). A lower incidence of embolic events was also observed in group P (3% vs. 25%, p < 0.05). Nine of 16 patients with embolic events in group V died of complications following embolism (8 patients; cerebral embolism, one patients: renal and superior mesenteric arterial embolism). The survival rates at 5 and 10 years were 80% and 69%, respectively, for group P and 56% and 33% for group V (p < 0.01). Thus, with regard to permanent pacing for patients with sick sinus syndrome, physiological pacing should be selected for control of morbidity and total mortality.
95例60岁及以上因病态窦房结综合征植入永久起搏器的患者被分为两组:32例接受生理性起搏的患者(P组)和63例接受心室起搏的患者(V组)。P组的平均随访期为45.0±36.6个月,V组为50.3±37.8个月。P组阵发性心房颤动(Af)的发生率为28%,V组为71%(p<0.05)。P组稳定型Af的发生率也低于V组(9%对30%,p<0.05)。仅患有缓慢性心律失常的P组患者均无稳定型Af。然而,V组21例患有缓慢性心律失常的患者中有6例(29%)表现出稳定型Af。患有心动过缓-心动过速综合征(BTS)的P组与患有BTS的V组在稳定型Af方面无显著差异(19%对31%)。P组栓塞事件的发生率也较低(3%对25%,p<0.05)。V组16例发生栓塞事件的患者中有9例死于栓塞后的并发症(8例:脑栓塞,1例:肾和肠系膜上动脉栓塞)。P组5年和10年的生存率分别为80%和69%,V组为56%和33%(p<0.01)。因此,对于病态窦房结综合征患者的永久起搏,应选择生理性起搏以控制发病率和总死亡率。